Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
6,028
Views
81
CrossRef citations to date
0
Altmetric
Letter

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

Pengfei Wanga Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAORCID Iconhttps://orcid.org/0000-0003-2454-7652View further author information
ORCID Icon,
Lihong Liua Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Manoj S. Naira Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-5994-3957View further author information
ORCID Icon,
Michael T. Yinb Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Yang Luoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Qian Wangc Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA, USAView further author information
,
Ting Yuana Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Kanako Moria Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Axel Guzman Solisa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Masahiro Yamashitaa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Ankur Gargd W. M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USAView further author information
,
Lawrence J. Purpurab Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Justin C. Laracyb Division of Infectious Diseases, Department of Internal Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Jian Yua Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
,
Leemor Joshua-Tord W. M. Keck Structural Biology Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USAView further author information
,
Joseph Sodroskic Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA, USAView further author information
,
Yaoxing Huanga Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USAView further author information
&
David D. Hoa Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 2091-2093 | Received 19 Jul 2020, Accepted 09 Sep 2020, Published online: 25 Sep 2020

Citations (81)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Usha Rani Kandula, Techane Sisay Tuji, Dinkinesh Begna Gudeta, Kassech Leta Bulbula, Anwar Abdulwahed Mohammad, Ketema Diriba Wari & Ahmad Abbas. (2023) Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review. Journal of Blood Medicine 14, pages 159-187.
Read now
Sangyi Lee, Dong-Wook Lee, Jeong-Min Kim, Da-Won Kim, Ji-Yun Kim, Jeong-Ah Kim, Il-Hwan Kim, Jee Eun Rhee, Kyung-duk Min, Sung-il Cho, Eun-Jin Kim & Jung-Hoon Kwon. (2023) Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea. Emerging Microbes & Infections 12:2.
Read now
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Jian Yu, Yicheng Guo, Maple Wang, Jasper F.-W. Chan, Gabriele Cerutti, Sho Iketani, Lihong Liu, Zizhang Sheng, Zhiwei Chen, Kwok-Yung Yuen, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro & David D. Ho. (2022) A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses. Emerging Microbes & Infections 11:1, pages 147-157.
Read now
Lucia Spicuzza, Gianluca Sambataro, Martina Bonsignore, Salvatore Mancuso, Maria Provvidenza Pistorio & Carlo Vancheri. (2022) Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time. Infectious Diseases 54:6, pages 464-466.
Read now

Articles from other publishers (77)

Ali H. Aldoukhi, Panayiotis Bilalis, Dana M. Alhattab, Alexander U. Valle-Pérez, Hepi H. Susapto, Rosario Pérez-Pedroza, Emiliano Backhoff-García, Sarah M. Alsawaf, Salwa Alshehri, Hattan Boshah, Abdulelah A. Alrashoudi, Waleed A. Aljabr, Manal Alaamery, May Alrashed, Rana M. Hasanato, Raed A. Farzan, Roua A. Alsubki, Manola Moretti, Malak S. Abedalthagafi & Charlotte A. E. Hauser. (2023) Fusing Peptide Epitopes for Advanced Multiplex Serological Testing for SARS-CoV-2 Antibody Detection. ACS Bio & Med Chem Au 4:1, pages 37-52.
Crossref
Charles W. Stratton & Yi-Wei Tang. 2024. Molecular Medical Microbiology. Molecular Medical Microbiology 2697 2726 .
Stefan Holdenrieder, Carlos Eduardo Dos Santos Ferreira, Jacques Izopet, Elitza S. Theel & Andreas Wieser. (2023) Clinical and laboratory considerations: determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19. Frontiers in Public Health 11.
Crossref
Diego Cantoni, Craig Wilkie, Emma M. Bentley, Martin Mayora-Neto, Edward Wright, Simon Scott, Surajit Ray, Javier Castillo-Olivares, Jonathan Luke Heeney, Giada Mattiuzzo & Nigel James Temperton. (2023) Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Frontiers in Immunology 14.
Crossref
Takayuki Uematsu, Tomomi Takano, Hidehito Matsui, Noritada Kobayashi, Satoshi Ōmura & Hideaki Hanaki. (2023) Prophylactic administration of ivermectin attenuates SARS-CoV-2 induced disease in a Syrian Hamster Model. The Journal of Antibiotics 76:8, pages 481-488.
Crossref
Gözde Akkuş Kayalı, Seyfi Durmaz, İrem Nur Şahin, Betül Akkul, Raika Durusoy, Funda Karbek Akarca, Sezgin Ulukaya & Candan Çiçek. (2023) COVID-19 Infection, Vaccination, and Antibody Levels: Investigating Correlations through a Cohort Study. Vaccines 11:7, pages 1258.
Crossref
Manoj S. Nair, Ruy M. Ribeiro, Maple Wang, Anthony D. Bowen, Lihong Liu, Yicheng Guo, Jennifer Y. Chang, Pengfei Wang, Zizhang Sheng, Magdalena E. Sobieszczyk, Alan S. Perelson, Yaoxing Huang & David D. Ho. (2023) Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost. iScience 26:4, pages 106345.
Crossref
Stéphanie Pons, Fabrice Uhel, Eric Frapy, Youssouf Sérémé, Lara Zafrani, Hugues Aschard & David Skurnik. (2022) How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response?. Stem Cell Reviews and Reports 19:3, pages 585-600.
Crossref
Isadora Maria Pilati Campos, Milena Marques, Gabrielle Caroline Peiter, Ana Paula Carneiro Brandalize, Mauricio Bedim dos Santos, Fabrício Freire de Melo & Kádima Nayara Teixeira. (2023) Temporal pattern of humoral immune response in mild cases of COVID-19. World Journal of Biological Chemistry 14:2, pages 40-51.
Crossref
Md. Imam Hossain, Protim Sarker, Rubhana Raqib, Md Ziaur Rahman, Rezaul Hasan, Chloe K. Svezia, Mahbubur Rahman & Nuhu Amin. (2023) Antibody response to different COVID-19 vaccines among the migrant workers of Bangladesh. Frontiers in Immunology 14.
Crossref
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Lotte S. Mikkelsen, Ulrik Fahnøe, Signe Bollerup, Anni Assing Winckelmann, Uffe Vest Schneider, Alekxander Binderup, Greta Vizgirda, Anna-Louise Sørensen, Caroline Nørløv Vinten, Magnus Illum Dalegaard, Santseharay Ramirez, Nina Weis & Jens Bukh. (2023) Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination. eBioMedicine 89, pages 104475.
Crossref
Endeshaw Chekol Abebe & Tadesse Asmamaw Dejenie. (2023) Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications. Frontiers in Immunology 14.
Crossref
Giuseppa Visalli, Antonio Laganà, Daniela Lo Giudice, Sebastiano Calimeri, Daniela Caccamo, Alessandra Trainito, Angela Di Pietro & Alessio Facciolà. (2023) Towards a Future of Personalized Vaccinology: Study on Individual Variables Influencing the Antibody Response to the COVID-19 Vaccine. Vaccines 11:2, pages 217.
Crossref
Beomki Lee, Jae-Hoon Ko, Jin Yang Baek, Haein Kim, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Kyong Ran Peck & Eun-Suk Kang. (2023) Clinical Utility of Sero-Immunological Responses Against SARS-CoV-2 Nucleocapsid Protein During Subsequent Prevalence of Wild-Type, Delta Variant, and Omicron Variant. Journal of Korean Medical Science 38:37.
Crossref
Wendimi Fatimata Belem, Ching-Hsuan Liu, Yee-Tung Hu, Thierry Burnouf & Liang-Tzung Lin. (2022) Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Viruses 14:11, pages 2419.
Crossref
Concepción Violán, Pere Torán-Monserrat, Bibiana Quirant, Noemi Lamonja-Vicente, Lucía A. Carrasco-Ribelles, Carla Chacón, Josep Maria Manresa-Dominguez, Francesc Ramos-Roure, Rosalia Dacosta-Aguayo, Cristina Palacios-Fernández, Albert Roso-Llorach, Aleix Pujol, Dan Ouchi, Mónica Monteagudo, Pilar Montero-Alia, Rosa Garcia-Sierra, Fernando Arméstar, Maria Doladé, Nuria Prat, Josep Maria Bonet, Bonaventura Clotet, Ignacio Blanco, Marc Boigues-Pons, Nemesio Moreno-Millán, Julia G. Prado, Eva María Martínez Cáceres, Marta Soldevilla Garcia, Ester Moral Roldan, Magda Alemany Costa, Eva Olivares Ortega, Alba Pachón Camacho, Marta Bujalance Devesa, Mariella Soto Espinoza, Antonio Negrete Palma, Mariana Martinez de San José, Ester Lucas Varas, Ester Badia Perich, Mónica Piña Rodriguez, Elena Domenech Graells, Eduard Moreno Gabriel, Victòria Sabaté Cintas, Mª Jose Argerich González, Asumció Vazquez Duran, Alex Ortega Roca, Anna Devesa Pradells, Athina Kielpilanen, Oscar Blanch Lombarte, Miguel Angel Marin Lopez, Julieta Carabelli, Ruth Peña Poderós, Esther Jimenez Moyano, Eulalia Grau Segura, Laia Bernard Rosa, Raul Pérez Caballero, Felipe Rodriguez Lozano, Gema Fernández Rivas, Sonia Molinos Abos, Jaume Barallat Martinez de Osaba, Lorena Tello Trigo, Cristina Perez Cano, Juan Matllo Aguilar, Anabel López Martínez & Inmaculada Agüera Iglesias. (2022) Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study. BMC Infectious Diseases 22:1.
Crossref
Harmony L Tyner, Jefferey L Burgess, Lauren Grant, Manjusha Gaglani, Jennifer L Kuntz, Allison L Naleway, Natalie J Thornburg, Alberto J Caban-Martinez, Sarang K Yoon, Meghan K Herring, Shawn C Beitel, Lenee Blanton, Janko Nikolich-Zugich, Matthew S Thiese, Jessica Flores Pleasants, Ashley L Fowlkes, Karen Lutrick, Kayan Dunnigan, Young M Yoo, Spencer Rose, Holly Groom, Jennifer Meece, Meredith G Wesley, Natasha Schaefer-Solle, Paola Louzado-Feliciano, Laura J Edwards, Lauren E W Olsho & Mark G Thompson. (2022) Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection. Clinical Infectious Diseases 75:1, pages e827-e837.
Crossref
Federica Zavaglio, Irene Cassaniti, Josè Camilla Sammartino, Stelvio Tonello, Pier Paolo Sainaghi, Viola Novelli, Federica Meloni, Daniele Lilleri & Fausto Baldanti. (2022) mRNA BNT162b Vaccine Elicited Higher Antibody and CD4+ T-Cell Responses than Patients with Mild COVID-19. Microorganisms 10:6, pages 1250.
Crossref
Min Li, Jiaojiao Liu, Renfei Lu, Yuchao Zhang, Meng Du, Man Xing, Zhenchuan Wu, Xiangyin Kong, Yufei Zhu, Xianchao Zhou, Landian Hu, Chiyu Zhang, Dongming Zhou & Xia Jin. (2022) Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals. Journal of Allergy and Clinical Immunology 149:4, pages 1225-1241.
Crossref
Kirsty McCance, Helen Wise, Jennifer Simpson, Becky Batchelor, Harriet Hale, Lindsay McDonald, Azul Zorzoli, Elizabeth Furrie, Charu Chopra, Frauke Muecksch, Theodora Hatziioannou, Paul D. Bieniasz, Kate Templeton & Sara Jenks. (2022) Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting. PLOS ONE 17:3, pages e0266086.
Crossref
Amanda J. Griffin, Kyle L. O’Donnell, Kyle Shifflett, John-Paul Lavik, Patrick M. Russell, Michelle K. Zimmerman, Ryan F. Relich & Andrea Marzi. (2022) Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern. Scientific Reports 12:1.
Crossref
Diego Cantoni, Martin Mayora-Neto, Angalee Nadesalingam, David A. Wells, George W. Carnell, Luis Ohlendorf, Matteo Ferrari, Phil Palmer, Andrew C.Y. Chan, Peter Smith, Emma M. Bentley, Sebastian Einhauser, Ralf Wagner, Mark Page, Gianmarco Raddi, Helen Baxendale, Javier Castillo-Olivares, Jonathan Heeney & Nigel Temperton. (2022) Neutralisation Hierarchy of SARS-CoV-2 Variants of Concern Using Standardised, Quantitative Neutralisation Assays Reveals a Correlation With Disease Severity; Towards Deciphering Protective Antibody Thresholds. Frontiers in Immunology 13.
Crossref
Elizabeth Smerczak. (2022) SARS-CoV-2 Antibody Testing: Where Are We Now?. Laboratory Medicine 53:2, pages e19-e29.
Crossref
Li-na Yan, Pan-pan Liu, Xu-gui Li, Shi-jing Zhou, Hao Li, Zhi-yin Wang, Feng Shen, Bi-chao Lu, Yu Long, Xiao Xiao, Zhen-dong Wang, Dan Li, Hui-ju Han, Hao Yu, Shu-han Zhou, Wen-liang Lv & Xue-jie Yu. (2022) Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection. Frontiers in Microbiology 12.
Crossref
Patricia R. Slev. (2022) Severe Acute Respiratory Syndrome Coronavirus 2 Serology Testing – A Laboratory Primer. Clinics in Laboratory Medicine 42:1, pages 1-13.
Crossref
Elif B. Uysal, Sibel Gümüş, Bayhan Bektöre, Hale Bozkurt & Ayşegül Gözalan. (2021) Evaluation of antibody response after COVID‐19 vaccination of healthcare workers. Journal of Medical Virology 94:3, pages 1060-1066.
Crossref
Sanda Ravlić, Ana Hećimović, Tihana Kurtović, Jelena Ivančić Jelečki, Dubravko Forčić, Anamarija Slović, Ivan Christian Kurolt, Željka Mačak Šafranko, Tatjana Mušlin, Dina Rnjak, Ozren Jakšić, Ena Sorić, Gorana Džepina, Oktavija Đaković Rode, Kristina Kujavec Šljivac, Tomislav Vuk, Irena Jukić, Alemka Markotić & Beata Halassy. (2022) Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?. Frontiers in Immunology 13.
Crossref
M. Gordon Joyce, Hannah A. D. King, Ines Elakhal-Naouar, Aslaa Ahmed, Kristina K. Peachman, Camila Macedo Cincotta, Caroline Subra, Rita E. Chen, Paul V. ThomasWei-Hung ChenRajeshwer S. SankhalaAgnes HajduczkiElizabeth J. Martinez, Caroline E. Peterson, William C. Chang, Misook Choe, Clayton SmithParker J. Lee, Jarrett A. Headley, Mekdi G. TaddeseHanne A. ElyardAnthony CookAlexander Anderson, Kathryn McGuckin Wuertz, Ming DongIsabella Swafford, James Brett Case, Jeffrey R. Currier, Kerri G. LalSebastian Molnar, Manoj S. Nair, Vincent Dussupt, Sharon P. DayeXiankun Zeng, Erica K. Barkei, Hilary M. StaplesKendra Alfson, Ricardo Carrion, Shelly J. Krebs, Dominic Paquin-Proulx, Nicos Karasavva, Victoria R. PolonisLinda L. Jagodzinski, Mihret F. Amare, Sandhya Vasan, Paul T. Scott, Yaoxing Huang, David D. Ho, Natalia de Val, Michael S. Diamond, Mark G. Lewis, Mangala Rao, Gary R. Matyas, Gregory D. Gromowski, Sheila A. PeelNelson L. Michael, Diane L. Bolton & Kayvon Modjarrad. (2022) A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Science Translational Medicine 14:632.
Crossref
Lawrence J. Purpura, Michelle Chang, Medini K. Annavajhala, Hiroshi Mohri, Lihong Liu, Jayesh Shah, Anyelina Cantos, Nicola Medrano, Justin Laracy, Brian Scully, Benjamin A. Miko, Marlena Habal, Marcus R. Pereira, Moriya Tsuji, David D. Ho, Anne-Catrin Uhlemann & Michael T. Yin. (2022) Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient. American Journal of Transplantation 22:2, pages 649-653.
Crossref
Makoto Kurano, Hiroko Ohmiya, Yoshiro Kishi, Jun Okada, Yuki Nakano, Rin Yokoyama, Chungen Qian, Fuzhen Xia, Fan He, Liang Zheng, Yi Yu, Daisuke Jubishi, Koh Okamoto, Kyoji Moriya, Tatsuhiko Kodama & Yutaka Yatomi. (2022) Measurement of SARS-CoV-2 Antibody Titers Improves the Prediction Accuracy of COVID-19 Maximum Severity by Machine Learning in Non-Vaccinated Patients. Frontiers in Immunology 13.
Crossref
Ikuro Matsuba, Tetsuo Takuma, Nobuo Hatori, Masahiko Takai, Yoshiyuki Watanabe, Nobukazu Takada, Satoru Kishi, Yoko Matsuzawa, Tetsuo Nishikawa, Tomoyuki Kunishima, Hisakazu Degawa, Masanori Nishikawa, Yoshiaki Ono & Akira Kanamori. (2022) Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections. Internal Medicine 61:2, pages 159-165.
Crossref
Christina Sølund, Alexander P. Underwood, Carlota Fernandez-Antunez, Signe Bollerup, Lotte S. Mikkelsen, Signe Lysemose Villadsen, Ulrik Fahnøe, Anni Assing Winckelmann, Shan Feng, Caroline A. Nørløv Vinten, Magnus Illum Dalegaard, Greta Vizgirda, Anna-Louise Sørensen, Santseharay Ramirez, Jens Bukh & Nina Weis. (2022) Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA–mRNA or Vector–mRNA COVID-19 Vaccines. Vaccines 10:1, pages 75.
Crossref
Siqi Li, Xiaoli Wang, Li Li, Yang Pan, Siyuan Yang, Dawei Tan, Ying Shen, Peng Yang, Naor Bar-Zeev, Yaling Hu, Jacky M. Jennings, Simin Li, Linghang Wang & Quanyi Wang. (2022) Factors Associated with SARS-CoV-2 Repeat Positivity — Beijing, China, June–September 2020. China CDC Weekly 4:5, pages 88-95.
Crossref
Lawrence J. Purpura, Joseph Alukal, Alexander M. Chong, Lihong Liu, Anyelina Cantos, Jayesh Shah, Nicola Medrano, Jennifer Y. Chang, Moriya Tsuji, Hiroshi Mohri, Anne Catrin Uhlemann, David Ho & Michael T. Yin. (2022) SARS-CoV-2 RNA Shedding in Semen and Oligozoospermia of Patient with Severe Coronavirus Disease 11 Weeks after Infection. Emerging Infectious Diseases 28:1, pages 196-200.
Crossref
Dongling Wu, Xinmin Zhang, Yonah Ziemba, Nina Haghi, Judith Brody & Peihong Hsu. (2022) Dynamics of Peripheral Blood T-lymphocytes Have Predictive Values for the Clinical Outcome of COVID-19 Patients in Intensive Care Unit. Clinical Pathology 15, pages 2632010X2110728.
Crossref
Faizan Zarreen Simnani, Dibyangshee Singh & Ramneet Kaur. (2021) COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review. 3 Biotech 12:1.
Crossref
Shelly Karuna, Shuying Sue Li, Shannon Grant, Stephen R. Walsh, Ian Frank, Martin Casapia, Meg Trahey, Ollivier Hyrien, Leigh Fisher, Maurine D. Miner, April K. Randhawa, Laura Polakowski, James G. Kublin, Lawrence Corey & David Montefiori. (2021) Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. PLOS Medicine 18:12, pages e1003868.
Crossref
Gregory Milne, Thomas Hames, Chris Scotton, Nick Gent, Alexander Johnsen, Roy M Anderson & Tom Ward. (2021) Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?. The Lancet Respiratory Medicine 9:12, pages 1450-1466.
Crossref
Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Diana Brlek-Gorski, Ivana Ferencak, Thomas Ferenc, Magdalena Ujevic-Bosnjak, Irena Tabain, Natasa Janev-Holcer, Ivana Perkovic, Mario Anticevic, Barbara Bekavac, Bernard Kaic, Anna Mrzljak, Marin Ganjto, Ljiljana Zmak, Maja Mauric Maljkovic, Pavle Jelicic, Lovro Bucic & Ljubo Barbic. (2021) Emerging Trends in the Epidemiology of COVID-19: The Croatian ‘One Health’ Perspective. Viruses 13:12, pages 2354.
Crossref
Federica Zavaglio, Vanessa Frangipane, Monica Morosini, Elisa Gabanti, Paola Zelini, Josè Camilla Sammartino, Alessandro Ferrari, Marilena Gregorini, Teresa Rampino, Annalia Asti, Elena Seminari, Angela Di Matteo, Barbara Cattadori, Carlo Pellegrini, Stelvio Tonello, Venkata Ramana Mallela, Rosalba Minisini, Manuela Rizzi, Pier Paolo Sainaghi, Federica Meloni, Daniele Lilleri & Fausto Baldanti. (2021) Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients. Viruses 13:11, pages 2261.
Crossref
Aleksander Szymczak, Natalia Jędruchniewicz, Alessandro Torelli, Agata Kaczmarzyk-Radka, Rosa Coluccio, Marlena Kłak, Andrzej Konieczny, Stanisław Ferenc, Wojciech Witkiewicz, Emanuele Montomoli, Paulina Miernikiewicz, Remigiusz Bąchor & Krystyna Dąbrowska. (2021) Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples. Journal of General Virology 102:11.
Crossref
Andrey A. Gorchakov, Sergey V. Kulemzin, Sergey V. Guselnikov, Konstantin O. Baranov, Tatyana N. Belovezhets, Ludmila V. Mechetina, Olga Yu. Volkova, Alexander M. Najakshin, Nikolai A. Chikaev, Anton N. Chikaev, Pavel P. Solodkov, Victor F. Larichev, Marina A. Gulyaeva, Alexander G. Markhaev, Yulia V. Kononova, Alexander Yu. Alekseyev, Alexander M. Shestopalov, Gaukhar M. Yusubalieva, Tatiana V. Klypa, Alexander V. Ivanov, Vladimir T. Valuev-Elliston, Vladimir P. Baklaushev & Alexander V. Taranin. (2021) Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern. Cell Discovery 7:1.
Crossref
Bailey B. Banach, Gabriele Cerutti, Ahmed S. Fahad, Chen-Hsiang Shen, Matheus Oliveira De Souza, Phinikoula S. Katsamba, Yaroslav Tsybovsky, Pengfei Wang, Manoj S. Nair, Yaoxing Huang, Irene M. Francino-Urdániz, Paul J. Steiner, Matías Gutiérrez-González, Lihong Liu, Sheila N. López Acevedo, Alexandra F. Nazzari, Jacy R. Wolfe, Yang Luo, Adam S. Olia, I-Ting Teng, Jian Yu, Tongqing Zhou, Eswar R. Reddem, Jude Bimela, Xiaoli Pan, Bharat Madan, Amy D. Laflin, Rajani Nimrania, Kwok-Yung Yuen, Timothy A. Whitehead, David D. Ho, Peter D. Kwong, Lawrence Shapiro & Brandon J. DeKosky. (2021) Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses. Cell Reports 37:1, pages 109771.
Crossref
Rabia Bag Soytas, Mahir Cengiz, Mehmet Sami Islamoglu, Betul Borku Uysal, Hande Ikitimur, Hakan Yavuzer & Serap Yavuzer. (2021) Does the COVID‐19 seroconversion in older adults resemble the young?. Journal of Medical Virology 93:10, pages 5777-5782.
Crossref
Yuying Lu, Jin Wang, Qianlin Li, Huan Hu, Jiahai Lu & Zeliang Chen. (2021) Advances in Neutralization Assays for SARS‐CoV‐2. Scandinavian Journal of Immunology 94:3.
Crossref
Y Victoria Zhang, Joesph Wiencek, Qing H Meng, Elitza S Theel, Nikolina Babic, Lusia Sepiashvili, Nicole D Pecora, Patricia Slev, Andrew Cameron & Danijela Konforte. (2021) AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency Use Authorization and Laboratory-Developed Test Serologic Testing in Clinical Laboratories. Clinical Chemistry 67:9, pages 1188-1200.
Crossref
Ghobad Moradi, Amjad Mohamadi Bolbanabad, Sanaz Ahmadi, Abbas Aghaei, Fares Bahrami, Arshad Veysi, Rasool Nasiri Kalmarzi, Azad Shokri, Ebrahim Ghaderi, Behzad Mohsenpour & Asadollah Mohammadi. (2021) Persistence assessment of SARS-CoV-2-specific IgG antibody in recovered COVID-19 individuals and its association with clinical symptoms and disease severity: A prospective longitudinal cohort study. International Immunopharmacology 98, pages 107893.
Crossref
Alexander P. Underwood, Christina Sølund, Carlota Fernandez-Antunez, Signe Lysemose Villadsen, Anni Assing Winckelmann, Signe Bollerup, Lotte S. Mikkelsen, Anna-Louise Sørensen, Shan Feng, Ulrik Fahnøe, Ria Lassauniere, Anders Fomsgaard, Santseharay Ramirez, Nina Weis & Jens Bukh. (2021) Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19. eBioMedicine 71, pages 103519.
Crossref
Haya Altawalah. (2021) Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination. Vaccines 9:8, pages 910.
Crossref
Justin C. Laracy, Benjamin A. Miko & Marcus R. Pereira. (2021) The solid organ transplant recipient with SARS-CoV-2 infection. Current Opinion in Organ Transplantation 26:4, pages 412-418.
Crossref
Angelika Wagner, Angela Guzek, Johanna Ruff, Joanna Jasinska, Ute Scheikl, Ines Zwazl, Michael Kundi, Hannes Stockinger, Maria R. Farcet, Thomas R. Kreil, Eva Hoeltl & Ursula Wiedermann. (2021) Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults. Communications Medicine 1:1.
Crossref
Mirella Mourad, Taylor Jacob, Elena Sadovsky, Shai Bejerano, Glicella Salazar-De Simone, Tarique Rajasaheb Bagalkot, Jason Zucker, Michael T. Yin, Jennifer Y. Chang, Lihong Liu, Larisa Debelenko, Carrie J. Shawber, Morgan Firestein, Yingshi Ouyang, Cynthia Gyamfi-Bannerman, Anna Penn, Alexander Sorkin, Ronald Wapner & Yoel Sadovsky. (2021) Placental response to maternal SARS-CoV-2 infection. Scientific Reports 11:1.
Crossref
Jianliang Xu, Kai Xu, Seolkyoung Jung, Andrea Conte, Jenna Lieberman, Frauke Muecksch, Julio Cesar Cetrulo Lorenzi, Solji Park, Fabian Schmidt, Zijun Wang, Yaoxing Huang, Yang Luo, Manoj S. Nair, Pengfei Wang, Jonathan E. Schulz, Lino Tessarollo, Tatsiana Bylund, Gwo-Yu Chuang, Adam S. Olia, Tyler Stephens, I-Ting Teng, Yaroslav Tsybovsky, Tongqing Zhou, Vincent Munster, David D. Ho, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig, Peter D. Kwong & Rafael Casellas. (2021) Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants. Nature 595:7866, pages 278-282.
Crossref
Javad Payandehpeyman, Neda Parvini, Kambiz Moradi & Nima Hashemian. (2021) Detection of SARS-CoV-2 Using Antibody–Antigen Interactions with Graphene-Based Nanomechanical Resonator Sensors. ACS Applied Nano Materials 4:6, pages 6189-6200.
Crossref
Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Maja Ilic, Ljubo Barbic, Krunoslav Capak, Irena Tabain, Jasna Lenicek Krleza, Thomas Ferenc, Zeljka Hruskar, Renata Zrinski Topic, Vanja Kaliterna, Arlen Antolovic-Pozgain, Jasmina Kucinar, Iva Koscak, Dijana Mayer, Mario Sviben, Ljiljana Antolasic, Ljiljana Milasincic, Lovro Bucic, Ivana Ferencak & Bernard Kaic. (2021) SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia. Pathogens 10:6, pages 774.
Crossref
Tiandan Xiang, Boyun Liang, Yaohui Fang, Sihong Lu, Sumeng Li, Hua Wang, Huadong Li, Xiaoli Yang, Shu Shen, Bin Zhu, Baoju Wang, Jun Wu, Jia Liu, Mengji Lu, Dongliang Yang, Ulf Dittmer, Mirko Trilling, Fei Deng & Xin Zheng. (2021) Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset. Frontiers in Immunology 12.
Crossref
Maya F. Amjadi, Sarah E. O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep R. Narpala, Peter J. Halfmann, S. Janna Bashar, Christopher R. Glover, Anna S. Heffron, Alison Taylor, Britta Flach, David H. O’Connor, Yoshihiro Kawaoka, Adrian B. McDermott, Ajay K. Sethi & Miriam A. Shelef. (2021) Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2. ImmunoHorizons 5:6, pages 466-476.
Crossref
Pengfei Wang, Manoj S. Nair, Lihong Liu, Sho Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, Peter D. Kwong, Barney S. Graham, John R. Mascola, Jennifer Y. Chang, Michael T. Yin, Magdalena Sobieszczyk, Christos A. Kyratsous, Lawrence Shapiro, Zizhang Sheng, Yaoxing Huang & David D. Ho. (2021) Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature 593:7857, pages 130-135.
Crossref
Monika Lindemann, Veronika Lenz, Dietmar Knop, Hannes Klump, Mira Alt, Ulrich W. Aufderhorst, Leonie Schipper, Sina Schwarzkopf, Lara Meller, Nina Steckel, Michael Koldehoff, Andreas Heinold, Falko M. Heinemann, Johannes Fischer, Gabriele Hutschenreuter, Cornelius Knabbe, Sebastian Dolff, Thorsten Brenner, Ulf Dittmer, Oliver Witzke, Frank Herbstreit, Peter A. Horn & Adalbert Krawczyk. (2021) Convalescent plasma treatment of critically ill intensive care COVID ‐19 patients . Transfusion 61:5, pages 1394-1403.
Crossref
Silvano Wendel, Rita Fontão‐Wendel, Roberta Fachini, Gabriela Candelaria, Patricia Scuracchio, Ruth Achkar, Mayra Brito, Luiz Fernando Reis, Anamaria Camargo, Mariane Amano, Rafael Machado, Danielle Araujo, Camila Soares & Edison Durigon. (2021) A longitudinal study of convalescent plasma ( CCP ) donors and correlation of ABO group, initial neutralizing antibodies ( nAb ), and body mass index ( BMI ) with nAb and anti‐nucleocapsid ( NP ) SARS‐CoV ‐2 antibody kinetics: Proposals for better quality of CCP collections . Transfusion 61:5, pages 1447-1460.
Crossref
Pengfei Wang, Ryan G. Casner, Manoj S. Nair, Maple Wang, Jian Yu, Gabriele Cerutti, Lihong Liu, Peter D. Kwong, Yaoxing Huang, Lawrence Shapiro & David D. Ho. (2021) Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host & Microbe 29:5, pages 747-751.e4.
Crossref
Georg Semmler, Marianna Theresia Traugott, Marianne Graninger, Wolfgang Hoepler, Tamara Seitz, Hasan Kelani, Mario Karolyi, Erich Pawelka, Sara Aragón de La Cruz, Elisabeth Puchhammer-Stöckl, Stephan Walter Aberle, Karin Stiasny, Alexander Zoufaly, Judith Helene Aberle & Lukas Weseslindtner. (2021) Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. Journal of Clinical Microbiology 59:5.
Crossref
Dongyan Zhou, Jasper Fuk-Woo Chan, Biao Zhou, Runhong Zhou, Shuang Li, Sisi Shan, Li Liu, Anna Jinxia Zhang, Serena J. Chen, Chris Chung-Sing Chan, Haoran Xu, Vincent Kwok-Man Poon, Shuofeng Yuan, Cun Li, Kenn Ka-Heng Chik, Chris Chun-Yiu Chan, Jianli Cao, Chun-Yin Chan, Ka-Yi Kwan, Zhenglong Du, Thomas Tsz-Kan Lau, Qi Zhang, Jie Zhou, Kelvin Kai-Wang To, Linqi Zhang, David D. Ho, Kwok-Yung Yuen & Zhiwei Chen. (2021) Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies. Cell Host & Microbe 29:4, pages 551-563.e5.
Crossref
Xia Feng, Jiming Yin, Jiaying Zhang, Yaling Hu, Yabo Ouyang, Shubin Qiao, Hong Zhao, Tong Zhang, Xuemei Li, Lili Zhang, Jie Zhang, Ronghua Jin, Yingmei Feng & Bin Su. (2021) Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China. Frontiers in Immunology 12.
Crossref
Vikram Srivastava, Ling Niu, Kruttika S. Phadke, Bryan H. Bellaire & Michael W. Cho. (2021) Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen. Frontiers in Immunology 12.
Crossref
Rachel West, Amanda Kobokovich, Nancy Connell & Gigi Kwik Gronvall. (2021) COVID-19 Antibody Tests: A Valuable Public Health Tool with Limited Relevance to Individuals. Trends in Microbiology 29:3, pages 214-223.
Crossref
Charles W. Stratton, Yi‐Wei Tang & Hongzhou Lu. (2020) Pathogenesis‐directed therapy of 2019 novel coronavirus disease. Journal of Medical Virology 93:3, pages 1320-1342.
Crossref
Hulda R. Jonsdottir, Michel Bielecki, Denise Siegrist, Thomas W. Buehrer, Roland Züst & Jeremy W. Deuel. (2021) Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults. Viruses 13:2, pages 284.
Crossref
Katharine H D Crawford, Adam S Dingens, Rachel Eguia, Caitlin R Wolf, Naomi Wilcox, Jennifer K Logue, Kiel Shuey, Amanda M Casto, Brooke Fiala, Samuel Wrenn, Deleah Pettie, Neil P King, Alexander L Greninger, Helen Y Chu & Jesse D Bloom. (2021) Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. The Journal of Infectious Diseases 223:2, pages 197-205.
Crossref
Heinz KohlerSrini Kaveri. (2021) How IvIg Can Mitigate Covid-19 Disease: A Symmetrical Immune Network Model. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 40:1, pages 17-20.
Crossref
Robert M. Humble, Anna E. Merrill, Bradley A. Ford, Daniel J. Diekema & Matthew D. Krasowski. (2021) Practical Considerations for Implementation of SARS-CoV-2 Serological Testing in the Clinical Laboratory: Experience at an Academic Medical Center. Academic Pathology 8, pages 23742895211002802.
Crossref
Andrew Bryan, Susan L Fink, Meghan A Gattuso, Gregory Pepper, Anu Chaudhary, Mark H Wener, Chihiro Morishima, Keith R Jerome, Patrick C Mathias & Alexander L Greninger. (2020) SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality. Open Forum Infectious Diseases 7:12.
Crossref
Yuezhou Chen, Adam Zuiani, Stephanie Fischinger, Jyotsna Mullur, Caroline Atyeo, Meghan Travers, Felipe J.N. Lelis, Krista M. Pullen, Hannah Martin, Pei Tong, Avneesh Gautam, Shaghayegh Habibi, Jillian Bensko, Deborah Gakpo, Jared Feldman, Blake M. Hauser, Timothy M. Caradonna, Yongfei Cai, John S. Burke, Junrui Lin, James A. Lederer, Evan Christopher Lam, Christy L. Lavine, Michael S. Seaman, Bing Chen, Aaron G. Schmidt, Alejandro Benjamin Balazs, Douglas A. Lauffenburger, Galit Alter & Duane R. Wesemann. (2020) Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production. Cell 183:6, pages 1496-1507.e16.
Crossref
Junsen Chen, Rui Huang, Yiwen Nie, Xinyue Wen & Ying Wu. (2021) Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19. Virologica Sinica 35:6, pages 713-724.
Crossref
Maximilian Koblischke, Marianna T. Traugott, Iris Medits, Felicia S. Spitzer, Alexander Zoufaly, Lukas Weseslindtner, Cara Simonitsch, Tamara Seitz, Wolfgang Hoepler, Elisabeth Puchhammer-Stöckl, Stephan W. Aberle, Manuela Födinger, Andreas Bergthaler, Michael Kundi, Franz X. Heinz, Karin Stiasny & Judith H. Aberle. (2020) Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity. Frontiers in Medicine 7.
Crossref
Giovanni Manzo. (2020) COVID-19 as an Immune Complex Hypersensitivity in Antigen Excess Conditions: Theoretical Pathogenetic Process and Suggestions for Potential Therapeutic Interventions. Frontiers in Immunology 11.
Crossref
Shuying Liu & Shan Lu. (2020) Antibody responses in COVID-19 patients. The Journal of Biomedical Research 34:6, pages 410.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.